Completion of Diagnostic Services sale
Source: RNS
2nd October 2023
Johnson Matthey Plc
(the Company)
Johnson Matthey announces completion of Diagnostic Services (also known as Tracerco) sale
Further to the announcement on 3rd May 2023, Johnson Matthey Plc (JM) is pleased to announce that it has completed the sale of its Diagnostic Services business on 29th September 2023 in accordance with the terms of the sale agreement entered into between JM and Sullivan Street Partners for a consideration of £55 million.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers' products. Our science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 15,000 Johnson Matthey professionals collaborate with our network of customers and partners to make a real difference to the world around us. For more information, visit www.matthey.com
ENDS
|
Enquiries:
|
|
|
|
Investor Relations Martin Dunwoodie Louise Curran Carla Fabiano |
Director of Investor Relations Senior Investor Relations Manager Senior Investor Relations Manager |
020 7269 8241 020 7269 8235 020 7269 8004 |
|
Media Harry Cameron |
Teneo |
020 7353 4200 |
|
|
|
|
Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)
Registered in England & Wales number: 00033774
Legal Entity Identifier number: 2138001AVBSD1HSC6Z10
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
